IRIS
FABRIS, Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.648
AS - Asia 3.859
EU - Europa 2.841
SA - Sud America 754
AF - Africa 79
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.195
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.507
SG - Singapore 1.815
CN - Cina 816
UA - Ucraina 624
BR - Brasile 611
IT - Italia 601
HK - Hong Kong 447
DE - Germania 438
VN - Vietnam 292
RU - Federazione Russa 274
FI - Finlandia 209
IE - Irlanda 156
GB - Regno Unito 135
IN - India 126
SE - Svezia 114
TR - Turchia 91
FR - Francia 75
CA - Canada 74
KR - Corea 54
AR - Argentina 46
MX - Messico 42
AT - Austria 41
BD - Bangladesh 37
ES - Italia 33
JP - Giappone 32
ID - Indonesia 29
ZA - Sudafrica 28
EC - Ecuador 27
BE - Belgio 25
NL - Olanda 24
PL - Polonia 24
IR - Iran 22
PY - Paraguay 19
IQ - Iraq 17
CO - Colombia 15
CL - Cile 11
EG - Egitto 11
TG - Togo 11
MA - Marocco 10
AU - Australia 9
JM - Giamaica 8
LT - Lituania 8
PE - Perù 8
PK - Pakistan 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
RO - Romania 7
AZ - Azerbaigian 6
BO - Bolivia 6
BY - Bielorussia 6
CZ - Repubblica Ceca 6
UZ - Uzbekistan 6
CH - Svizzera 5
IL - Israele 5
KZ - Kazakistan 5
MY - Malesia 5
UY - Uruguay 5
EE - Estonia 4
EU - Europa 4
HU - Ungheria 4
KG - Kirghizistan 4
NP - Nepal 4
SA - Arabia Saudita 4
TH - Thailandia 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
AM - Armenia 3
BG - Bulgaria 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
DZ - Algeria 2
HR - Croazia 2
KH - Cambogia 2
LV - Lettonia 2
OM - Oman 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GF - Guiana Francese 1
GH - Ghana 1
GM - Gambi 1
GR - Grecia 1
IM - Isola di Man 1
KW - Kuwait 1
LI - Liechtenstein 1
Totale 16.186
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.008
Singapore 776
Ann Arbor 768
Chandler 657
Fairfield 654
Ashburn 651
Houston 528
Beijing 470
Hong Kong 442
Jacksonville 435
Wilmington 315
Dearborn 287
Seattle 265
Boardman 202
Cambridge 200
Udine 161
Dublin 150
Princeton 145
Los Angeles 131
Dallas 112
Ho Chi Minh City 81
Munich 78
Izmir 77
Dong Ket 70
Redondo Beach 64
Hefei 62
San Diego 59
Buffalo 57
Redmond 56
São Paulo 56
Trieste 53
Hanoi 49
New York 49
Seoul 48
Norwalk 36
Ogden 36
Venezia 35
Santa Clara 31
Montreal 29
Nuremberg 27
Tokyo 27
Des Moines 26
Nanjing 26
Milan 25
Brussels 24
Guangzhou 24
Belluno 23
Mumbai 23
Ottawa 23
Denver 22
Düsseldorf 22
San Mateo 21
Warsaw 21
Phoenix 20
Rio de Janeiro 20
Stockholm 19
The Dalles 19
Chennai 18
Frankfurt am Main 18
Johannesburg 18
London 18
Leawood 17
Mexico City 16
Vienna 16
Amsterdam 15
Orem 15
Boston 14
Chicago 14
Helsinki 14
Kunming 14
Augusta 13
Belo Horizonte 13
Grafing 13
Lappeenranta 13
Lauterbourg 13
Querétaro 13
Toronto 13
Turku 13
Brooklyn 12
Poplar 12
Rome 12
Codroipo 11
Lomé 11
San Francisco 11
Tavagnacco 11
Ribeirão Preto 10
Salvador 10
Hyderabad 9
Miami 9
Ansbach 8
Atlanta 8
Auburn Hills 8
Baghdad 8
Biên Hòa 8
Brasília 8
Curitiba 8
Da Nang 8
Monmouth Junction 8
Paris 8
Portsmouth 8
Totale 10.312
Salva come PNG Salva come JPEG
Nome #
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 259
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 236
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 217
Twist is substrate for caspase cleavage and proteasome-mediated degradation 196
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 189
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 185
Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients 179
Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients 175
Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients 172
Cardiovascular Complications of Acromegaly. 163
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 163
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 162
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors 158
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 156
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 149
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 148
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! 145
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 141
BLyS and April serum levels in patients with autoimmune thyroid diseases. 140
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 140
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 140
The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases 139
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 137
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 134
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 134
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 132
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 132
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation 132
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 130
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 130
Anti-vimentin/cardiolipin complex autoantibodies in antiphospholipid syndrome: preliminary data using a new ELISA method. 129
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 128
Epidemiology of paraneoplastic neurological syndromes: a population-based study 127
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 126
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 125
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 123
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 120
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 113
B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Disease Behavior 113
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease 113
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 112
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 112
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 111
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 111
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 111
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 109
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 109
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 109
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 109
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 108
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 106
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 106
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 105
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 104
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 104
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 104
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 104
Non-malignant lymphoproliferation in Sjögren’s syndrome: proposed classification based on integrated clinico-pathologic and molecular studies and follow-up. 103
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 103
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS 102
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 102
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 102
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 101
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 100
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 99
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? 99
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results 98
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 98
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 98
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 97
Rankl and osteoprotegerin serum levels changes after rituximab therapy in rheumatoid arthritis: correlation with disease control and bone mineral density preservation 96
Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703) 95
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 95
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 94
Italy association of transforming growth factor-b (tgf-b) 869cc polymorphism with bone erosions in rheumatoid arthritis: an ultrasonographic study. 94
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 94
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 94
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 93
BlYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Factor, , vol 60 suppl 10 :1678 93
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 93
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis. 93
B-Lymphocyte Stimulator in neuroendocrine tumors: correlation with disease behaviour. 93
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 93
Evidence for an association between the -871 t/c promoter polymorphism in the b-lymphocyte stimulator (blys) gene and the development of an overt lymphoproliferative disorder in mixed cryoglobulinemia syndrome (mcsn) 92
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study 91
Controversies on rituximab therapy in Sjögren's syndrome-associated lymphoproliferation 90
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? 90
Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation. 89
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 89
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 89
Chlamydophila psittaci subclinical infection in chronic polyarthritis 88
The Effect of Osteoarthritic Synovial Fluid on Immunomodulatory Properties of Adipose Mesenchymal Stem Cells. 88
A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study 87
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 86
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents. 86
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents 86
Improving the diagnostic approach to type I diabetes: the introduction of anti-zinc transporter protein autoantibodies (ZnT8A)(835.15) 86
Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine 86
Metodo diagnostico e prognostico per la diagnosi e la prognosi della linfoproliferazione nelle malattie immunomediate organo specifiche e/o di pertinenza trasfusionale 85
An Italilan multicenter controlled study of HCV-related malignancies: role of the HLA class II. 85
Totale 11.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.094 0 0 0 0 0 173 74 161 283 54 232 117
2021/20221.147 62 122 35 94 51 29 44 62 13 176 280 179
2022/20231.542 167 116 9 234 126 382 23 136 206 18 65 60
2023/2024499 73 37 24 15 75 62 13 54 58 46 12 30
2024/20253.244 83 213 228 136 118 142 233 196 354 276 495 770
2025/20263.383 531 572 510 780 860 130 0 0 0 0 0 0
Totale 16.565